ScholarIQanswers from OpenAlex & ORCID
D. Lawrence Wickerham
ResearcherPublications, citations & collaboration network
D. Lawrence Wickerham is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does D. Lawrence Wickerham have?
ScholarIQindexed works
D. Lawrence Wickerham has 180 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does D. Lawrence Wickerham have?
ScholarIQcitation count
D. Lawrence Wickerham has 52,609 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of D. Lawrence Wickerham?
ScholarIQh-index
D. Lawrence Wickerham has an h-index of 71 in OpenAlex.
What is the i10-index of D. Lawrence Wickerham?
ScholarIQi10-index
D. Lawrence Wickerham has an i10-index of 118 in OpenAlex.
What is the OpenAlex record for D. Lawrence Wickerham?
ScholarIQopenalex
The OpenAlex for D. Lawrence Wickerham is on the source record.
What are the most-cited papers on D. Lawrence Wickerham?
ScholarIQmost cited works
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Bernard Fisher, John Bryant, Norman Wolmark, E.P. Mamounas, A Brown, Edwin R. Fisher, D. Lawrence Wickerham, Mirsada Begovič, Arthur P. DeCillis, A. Robidoux, Richard G. Margolese, Anatolio B. Cruz, James L. Hoehn, Alan Lees, N V Dimitrov, Harry D. Bear